CLASS I Drug recall · Reported 27 Jul 2022 · FDA Enforcement Report
Launch Sequence Euphoria Capsules tins, ASIN B08ZJX4V9J recalled
Loud Muscle Science is recalling Launch Sequence Euphoria Capsules tins, ASIN B08ZJX4V9J, distributed nationwide in the US. The recall was initiated on 27 Jun 2022 and the FDA has classified it as Class I.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-1337-2022
- FDA event ID
- 90551
- Recalling firm
- Loud Muscle Science, Hauppauge, NY
- Classification
- Class I
- Status
- Terminated
- Recall initiated
- 27 Jun 2022
- FDA classified
- 15 Aug 2022
- Reported
- 27 Jul 2022
- Type
- Voluntary: Firm initiated
- Customers notified by
- Press Release
- Reason category
- Labeling Errors
Timeline
| 27 Jun 2022 | Recall initiated by company | |
| 27 Jul 2022 | Published in enforcement report | +30 days |
| 15 Aug 2022 | Classified by FDA | +19 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Product as listed by the FDA
Launch Sequence Euphoria Capsules, 10- count tins, ASIN B08ZJX4V9J, UPC Code 661020846864.
Where it was distributed
The product was distributed nationwide in the USA and Canada.
Questions about this recall
Is Launch Sequence Euphoria Capsules tins, ASIN B08ZJX4V9J recalled?
Yes. Loud Muscle Science recalled Launch Sequence Euphoria Capsules tins, ASIN B08ZJX4V9J on 27 Jun 2022. The recall is Class I and its status is Terminated. Recall number D-1337-2022.
Why was it recalled?
Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Which lots are affected?
Lot # 2022104, Exp. Date 04/2025
Where was it sold?
The product was distributed nationwide in the USA and Canada.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class I mean?
Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Loud Muscle Science
All 6| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Launch Sequence Euphoria Capsules tins, ASIN B08ZJX4V9J recalled | Loud Muscle Science | Hidden Drug Ingredients | Nationwide |
| Drug | CLASS II | Launch Sequence Capsules, Dietary Supplement, ASIN B07TLPWXDS recalled | Loud Muscle Science | Hidden Drug Ingredients | Nationwide |
| Drug | CLASS II | Launch Sequence Aphrodisia Capsules tins, ASIN B07QB3S2LV recalled | Loud Muscle Science | Hidden Drug Ingredients | Nationwide |
| Drug | CLASS I | Launch Sequence Capsules, Dietary Supplement, ASIN B07TLPWXDS recalled | Loud Muscle Science | Labeling Errors | Nationwide |
| Drug | CLASS I | Launch Sequence Aphrodisia Capsules tins, ASIN B07QB3S2LV recalled | Loud Muscle Science | Labeling Errors | Nationwide |
Other Launch sequence euphoria recalls
All 2| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Launch Sequence Euphoria Capsules tins, ASIN B08ZJX4V9J recalled | Loud Muscle Science | Hidden Drug Ingredients | Nationwide |